Effects of Bardoxolone Methyl in Alport Syndrome.
Bradley A WaradyPablo E PergolaRajiv AgarwalSharon AndreoliGerald B AppelSripal BangaloreGeoffrey A BlockArlene B ChapmanMelanie P ChinKeisha L GibsonAngie GoldsberryKazumoto IijimaLesley A InkerClifford E KashtanBertrand KnebelmannLaura H MarianiColin J MeyerKandai NozuMegan O'GradyMichelle N RheaultArnold L SilvaPeter StenvinkelRoser TorraGlenn M ChertowPublished in: Clinical journal of the American Society of Nephrology : CJASN (2022)
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients with Alport Syndrome - CARDINAL (CARDINAL), NCT03019185.
Keyphrases